Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Change in Cash (2016 - 2025)

Historic Change in Cash for Lisata Therapeutics (LSTA) over the last 13 years, with Q3 2025 value amounting to $2.2 million.

  • Lisata Therapeutics' Change in Cash rose 12462.43% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$511000.0, marking a year-over-year increase of 9604.46%. This contributed to the annual value of -$6.4 million for FY2024, which is 3322.87% up from last year.
  • Lisata Therapeutics' Change in Cash amounted to $2.2 million in Q3 2025, which was up 12462.43% from -$3.4 million recorded in Q2 2025.
  • In the past 5 years, Lisata Therapeutics' Change in Cash registered a high of $8.7 million during Q3 2023, and its lowest value of -$9.8 million during Q4 2023.
  • Moreover, its 3-year median value for Change in Cash was -$3.3 million (2024), whereas its average is -$1.2 million.
  • Per our database at Business Quant, Lisata Therapeutics' Change in Cash crashed by 20052.64% in 2024 and then skyrocketed by 60862.94% in 2025.
  • Over the past 3 years, Lisata Therapeutics' Change in Cash (Quarter) stood at -$9.8 million in 2023, then soared by 66.45% to -$3.3 million in 2024, then skyrocketed by 165.55% to $2.2 million in 2025.
  • Its Change in Cash stands at $2.2 million for Q3 2025, versus -$3.4 million for Q2 2025 and $4.0 million for Q1 2025.